Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors.

Xingzhi Li,Jie Chen,Xiaobo Wang,Tao Bai,Shaolong Lu,Tao Wei,Zhihong Tang, Chengwen Huang,Bin Zhang,Bowen Liu,Lequn Li,Feixiang Wu

Frontiers in oncology（2023）

引用 1|浏览15

暂无评分

摘要

Early tumor response is an important predictive marker for successful conversion surgery and prolonged survival in patients with iuHCC treated using LTP conversion therapy. Conversion surgery is necessary to improve survival during conversion therapy, particularly for early responders.

查看译文

关键词

PD-1 inhibitors,conversion therapy,initially unresectable hepatocellular carcinoma,lenvatinib,transcatheter arterial chemoembolization

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要